Skip to content
OpenCapital
Get started

Core Laboratories CLB Increase (decrease) in contract liabilities and current deferred income

Increase (decrease) in contract liabilities and current deferred income at other companies

Forum Energy Technologies logo
Forum Energy TechnologiesFET
-$5.36M-563%
Baker Hughes logo
Baker HughesBKR
——

Other financials

Income statement

See full
Revenue$121.8M-1.4%
Operating income$1.9M-57.3%
Net income-$789.0K-412%
EPS (diluted)-$0.02—

Balance sheet

See full
Cash & equivalents$22.8M+3.2%
Total debt$167.8M-6.8%
Total equity$268.9M+6.1%
Total assets$587.7M+0.3%

Cash flow

See full
Operating cash flow$4.0M-40.5%
CapEx$3.4M+23.8%
Free cash flow$517.0K-86.7%

Valuation

See full
Market cap$492.77M-9.3%
Enterprise value$637.8M-7.6%
P/E17×-1.4×
P/S0.9×-0.1×

Profitability

See full
Operating margin10.3%-0.2pp
Net margin5.5%+0.1pp
FCF margin4.3%-4.6pp

Returns & leverage

See full
Return on equity11.1%-0.4pp
Debt / equity0.6×-0.1×
Current ratio2×-0.2×

Where this comes from

Reported directly by Core Laboratories in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInContractWithCustomerLiability.

The official record: Core Laboratories’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Core Laboratories's increase (decrease) in contract liabilities and current deferred income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Core Laboratories's increase (decrease) in contract liabilities and current deferred income?
Core Laboratories (CLB) reported increase (decrease) in contract liabilities and current deferred income of -$844K in Q1 2026.
How has Core Laboratories's increase (decrease) in contract liabilities and current deferred income changed year-over-year?
Core Laboratories's increase (decrease) in contract liabilities and current deferred income decreased by 291.8% year-over-year, from $440K to -$844K.
What is the long-term trend for Core Laboratories's increase (decrease) in contract liabilities and current deferred income?
Over 2 years (2021 to 2025), Core Laboratories's increase (decrease) in contract liabilities and current deferred income has grown at a 28.0% compound annual growth rate (CAGR), from $2.31M to -$3.78M.